Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
13 March, 2017
Neurology. 2017 Mar 7;88(10):930-937
Read the articleSystematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregationn in Alzheimer´s disease
Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):E200-E208. doi: 10.1073/pnas.1615613114.
Read the article